Viread® (tenofovir disoproxil fumarate) – Expanded indication
December 11, 2018 - The FDA approved Viread (tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B virus (HBV) in adults and pediatric patients 2 years of age and older weighing at least 10 kg.
Download PDF
